Ensign Peak Advisors, Inc Ascendis Pharma A/S Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 2,983 shares of ASND stock, worth $387,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,983

Previous 3,091 3.49%

Holding current value

$387,223

Previous $421,000 5.7%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$113.0 - $153.43 $12,204 - $16,570	-108 Reduced 3.49%	2,983 $445,000
Q2 2024 Aug 13, 2024	SELL	$121.07 - $153.67 $7.8 Million - $9.9 Million	-64,453 Reduced 95.42%	3,091 $421,000
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $12,888 - $15,491	-149 Reduced 0.22%	67,544 $6.32 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $4.44 Million - $5.89 Million	44,650 Added 193.77%	67,693 $8.27 Million
Q2 2022 Aug 12, 2022	BUY	$78.08 - $117.61 $486,984 - $733,533	6,237 Added 37.11%	23,043 $2.14 Million
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $355,075 - $471,731	-3,475 Reduced 17.13%	16,806 $1.97 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $329,951 - $440,437	2,596 Added 14.68%	20,281 $2.73 Million
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $1.24 Million - $1.95 Million	-11,000 Reduced 38.35%	17,685 $2.82 Million
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $4.65 Million - $5.55 Million	-38,197 Reduced 57.11%	28,685 $3.77 Million
Q1 2021 May 12, 2021	BUY	$124.92 - $173.33 $3.56 Million - $4.95 Million	28,537 Added 74.42%	66,882 $8.62 Million
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $1.92 Million - $2.32 Million	-12,695 Reduced 24.87%	38,345 $6.4 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $721,271 - $828,852	5,371 Added 11.76%	51,040 $7.88 Million
Q2 2020 Aug 12, 2020	BUY	$110.87 - $156.01 $300,568 - $422,943	2,711 Added 6.31%	45,669 $6.76 Million
Q1 2020 May 11, 2020	SELL	$97.01 - $145.11 $616,595 - $922,319	-6,356 Reduced 12.89%	42,958 $4.84 Million
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $4.51 Million - $6.86 Million	49,314 New	49,314 $6.86 Million

Others Institutions Holding ASND

# of Institutions

243

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.24B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Ascendis Pharma A/S Transaction History